Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125279591 | 12527959 | 1 | I | 20160623 | 20160705 | 20160705 | EXP | NL-TEVA-673908ISR | TEVA | VAN AALST J, TEERNSTRA OP, WEBER WE, RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL. 2016; 9:117-120 | 63.00 | YR | F | Y | 0.00000 | 20160705 | MD | NL | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125279591 | 12527959 | 1 | PS | MORPHINE | MORPHINE | 1 | Intrathecal | 3.5 MILLIGRAM DAILY; | Y | 202718 | |||||||||
125279591 | 12527959 | 2 | SS | MORPHINE | MORPHINE | 1 | Intrathecal | WEAN FROM THE DRUG WITH STEPS OF 0.5MG/DAY | Y | 202718 | |||||||||
125279591 | 12527959 | 3 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 1200 MILLIGRAM DAILY; | Y | 63027 | 300 | MG | QID | |||||||
125279591 | 12527959 | 4 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MILLIGRAM DAILY; | Y | 0 | QD | |||||||||
125279591 | 12527959 | 5 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 10 MILLIGRAM DAILY; | Y | 0 | ||||||||||
125279591 | 12527959 | 6 | SS | AMOXICILLIN W/CLAVULANIC ACID | AMOXICILLINCLAVULANIC ACID | 1 | 4 DOSAGE FORMS DAILY; | Y | 65096 | 1 | DF | QID | |||||||
125279591 | 12527959 | 7 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 15 MILLIGRAM DAILY; | Y | 70152 | 5 | MG | TID | ||||||
125279591 | 12527959 | 8 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | 100 MICROGRAM/HOUR | Y | 20747 | |||||||||
125279591 | 12527959 | 9 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 80 MILLIGRAM DAILY; | Y | 0 | 20 | MG | QID | ||||||
125279591 | 12527959 | 10 | SS | AMOXICILLIN W/CLAVULANIC ACID | AMOXICILLINCLAVULANIC ACID | 1 | Intravenous (not otherwise specified) | Y | 65096 | QID | |||||||||
125279591 | 12527959 | 11 | SS | CLONIDINE. | CLONIDINE | 1 | Oral | .45 MILLIGRAM DAILY; | Y | 0 | .15 | MG | TID | ||||||
125279591 | 12527959 | 12 | C | PROPOFOL. | PROPOFOL | 1 | Y | 0 | |||||||||||
125279591 | 12527959 | 13 | C | SUFENTANIL | SUFENTANIL | 1 | Y | 0 | |||||||||||
125279591 | 12527959 | 14 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | Y | 0 | |||||||||||
125279591 | 12527959 | 15 | C | SEVOFLURANE. | SEVOFLURANE | 1 | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125279591 | 12527959 | 1 | Amputation stump pain |
125279591 | 12527959 | 2 | Amputation stump pain |
125279591 | 12527959 | 4 | Amputation stump pain |
125279591 | 12527959 | 5 | Amputation stump pain |
125279591 | 12527959 | 7 | Muscle spasms |
125279591 | 12527959 | 8 | Pain |
125279591 | 12527959 | 9 | Pain |
125279591 | 12527959 | 11 | Pain |
125279591 | 12527959 | 12 | General anaesthesia |
125279591 | 12527959 | 13 | General anaesthesia |
125279591 | 12527959 | 14 | General anaesthesia |
125279591 | 12527959 | 15 | General anaesthesia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125279591 | 12527959 | OT |
125279591 | 12527959 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125279591 | 12527959 | Drug withdrawal syndrome | |
125279591 | 12527959 | Hemiparesis | |
125279591 | 12527959 | Posterior reversible encephalopathy syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |